MIT’s new ‘recursive’ framework lets LLMs process 10 million tokens without context rot

While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...
InfoQ

MIT's Recursive Language Models Improve Performance on Long-Context Tasks

Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...
IEEE

Recursive System Identification of Continuous-Time Fractional Systems for All Parameter Estimation

Fractional-order systems have proven to be useful to well model diffusion or propagation phenomena. Recursive or online system identification of continuous-time fractional models is explored in this ...
GitHub

A lightweight, RFC-compliant LDAP server written in Go with SQLite backend. Built for simplicity and modern workflows.

Perfect for homelabs, development environments, and single-instance deployments where you need LDAP without the operational overhead. Also: This project serves as an experiment in building complex, ...
IEEE

Recursive Queries: Twenty-Five Years After SQL:1999

Abstract: SQL:1999 recursive queries are almost a quarter century old. In this standard the recursive queries have the form of recursive common table expressions. In recent years vendors of almost all ...
Yahoo Finance

JPMorgan Boosts Rating on Recursion Pharmaceuticals (RXRX) Amid AI-Driven Drug Pipeline

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, JPMorgan raised Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from a Neutral ...
marktechpost

Recursive Language Models (RLMs): From MIT’s Blueprint to Prime Intellect’s RLMEnv for Long Horizon LLM Agents

Recursive Language Models aim to break the usual trade off between context length, accuracy and cost in large language models. Instead of forcing a model to read a giant prompt in one pass, RLMs treat ...
The Motley Fool

Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy.

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.
Hosted on MSN

Cathie Wood’s ARK Investment buys 755K shares of Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the 12 Best Genomics Stocks to Invest In. Cathie Wood’s ARK Investment acquired 755,000 shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ...